Better Buy: Inovio Pharmaceuticals vs. Novavax [Yahoo! Finance]
Novavax, Inc. (NVAX)
Last novavax, inc. earnings: 3/11 04:17 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.novavax.com/investor-relations
Company Research
Source: Yahoo! Finance
That group includes Novavax (NASDAQ: NVAX) and Inovio Pharmaceuticals (NASDAQ: INO) . The former did launch a coronavirus vaccine in the U.S., but the latter never got that far. Both have substantially lagged the market over the past three years, but they now seem to be experiencing significant rebounds; shares of Novavax and Inovio have soared since 2024 started. Which of these two biotechs can outperform the other moving forward? Let's take a look. The case for Novavax Novavax earned approval for its COVID-19 vaccine, Nuvaxovid, in various countries. In the U.S., it is still under Emergency Use Authorization. However, the biotech is now seeking full approval. Novavax generated almost $1 billion in total revenue last year. In the first quarter, its top line came in at $93.9 million, higher than the $81 million reported in the prior-year period. Novavax initially projected that it would record sales of at most $1 billion this year. That was before striking a major agreement wi
Show less
Read more
Impact Snapshot
Event Time:
NVAX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NVAX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NVAX alerts
High impacting Novavax, Inc. news events
Weekly update
A roundup of the hottest topics
NVAX
News
- Novavax Submits Application to U.S. FDA for Updated Protein-based 2024-2025 Formula COVID-19 Vaccine [Yahoo! Finance]Yahoo! Finance
- Novavax Submits Application to U.S. FDA for Updated Protein-based 2024-2025 Formula COVID-19 VaccinePR Newswire
- Novavax, Inc. (NASDAQ: NVAX) had its price target raised by analysts at Bank of America Co. from $12.00 to $18.00. They now have a "neutral" rating on the stock.MarketBeat
- Bull Market and Beyond: 3 Stocks Just Waiting to Soar [Yahoo! Finance]Yahoo! Finance
- Novavax, Inc. (NASDAQ:NVAX) has caught the attention of institutional investors who hold a sizeable 49% stake [Yahoo! Finance]Yahoo! Finance
NVAX
Earnings
- 2/28/24 - Miss
NVAX
Analyst Actions
- 5/13/24 - HC Wainwright
NVAX
Sec Filings
- 6/14/24 - Form 4
- 6/14/24 - Form 4
- 6/14/24 - Form 4
- NVAX's page on the SEC website